Journal Of Clinical Oncology (jco) Podcast
Novel Insights From a Phase II MEK Inhibitor Trial in BRAF Mutant Melanoma
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:07:27
- More information
Informações:
Synopsis
A discussion of a phase 2 trial of a MEK inhibitor in patients with V600 BRAF mutations and consideration of other relevant results with targeted therapies in this population.
